We develop and operate advanced accelerator technology using sophisticated simulation techniques, from high-intensity cyclotrons, superconducting radiofrequency (SRF) linacs and colliders to high-power targets and ion-sources.

We use our proton and neutron beams to enable industry to de-risk electronics used in the aerospace and telecommunications sectors. We also use our proton beams to treat eye cancer. 

We develop and utilize radiopharmaceuticals for imaging, diagnosing, and treating a variety of life-threatening diseases as well as radiotracers used in industrial and environmental applications.

We push the discovery frontier at the highest energies with the Large Hadron Collider (LHC) at CERN in search of new physics beyond the Standard Model.

We utilize muons and rare isotopes as probes of the electronic and magnetic properties of quantum materials, advancing a broad spectrum of topics.

We utilize accelerator-based and deep underground experiments to elucidate the properties of neutrinos and to uncover the nature of dark matter particles.

We investigate nuclear properties and reactions of short-lived rare isotopes to gain insights into the origin of the chemical elements in the universe.

We develop new radiotracer molecules that can be attached to various biomolecules that target functions or diseases in the body, enabling their imaging, diagnosis, and treatment.

We investigate the nature of atomic nuclei using short-lived rare isotopes at the extremes of nuclear existence to develop a unified theory of all nuclei.

We carry out some of the most precise measurements of the fundamental interactions and symmetries to discover new physics beyond the Standard Model of particle physics.